DAX attacks 11,000 on COVID-19 cure hopes - sustainable?
Gilead Says Remdesivir Will Be Available To Patients This Week
Goldman Sachs: These 3 Stocks Are Poised to Surge by at Least 30%
Gilead Down 5% As Q1 Earnings Spark Street Downgrades
Weekly Market Review: An April to Remember
Gilead’s Remdesivir Receives Emergency FDA Approval; Here's What This Five-Star Analyst Has To Say
SFU professor’s invention approved by FDA to help wean COVID-19 patients from ventilators
Mid-Market Update: ‘Sell in May’ adage sounds about right, Dismal Data again, Oil giants slash capex, Gold climbs higher
High-profile R&D specialist David Lebwohl jumps to new job as CMO of a pioneering CRISPR player; Troubled AMAG Pharmaceuticals taps Scott Myers as CEO
Troubled AMAG Pharmaceuticals taps Scott Myers as CEO and president; Cheryl Blanchard secures CEO title at Anika Therapeutics
Which Companies Are Flourishing in a Covid-19 World?
Pharmacists warn against malarial drugs as a cure for coronavirus
Is Gilead Sciences Stock a Buy Right Now? This Is What You Need to Know
Novotech selected as CRO for Karyopharm’s COVID-19 clinical study
3 Monster Growth Stocks With Still Plenty of Gas in the Tank
Clinicians warn of the dangers of equating COVID-19 with high altitude pulmonary edema
UPDATED: GSK widens the market for Zejula as FDA signs off on the PARP inhibitor for use in ovarian cancer patients without BRCA mutations
Stock prediction for 2020 – is it possible?
Asia Session: Happy Birthday Buddha
New evidence for optimizing malaria treatment in pregnant women
Dollar falls after dovish FOMC meeting, Oil higher on demand pickup, Gold struggles
Expanding digital financial services can help developing economies cope with crisis now and boost growth later
COVID-19 (coronavirus): Universal health coverage in times of crisis
NIH mobilizes national innovation initiative for COVID-19 diagnostics
NYC Hospitals Turn to IBM’s Blockchain Tech for COVID-19 Relief